Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt share news and announcements
1,014 announcements, routine notices left out, newest first. Page 14 of 21.
Nov 2014
5 Nov · Legal
Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt: US export ban may stay till 2015". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.4 Nov · Dividend
Interim Dividend will be paid to the shareholders of the Company on or before December 02, 2014.4 Nov · Corporate action
Company has fixed Record Date as November 15, 2014 for the purpose of Interim Dividend.3 Nov · Dividend
Board of Directors of the Company at their meeting held on November 3, 2014 have declared an Interim Dividend of Rs. 20/- per equity share of face value of Rs. 5/- each i.e @ 400 % for the financial year 2014-15 on 110,040,403 equity shares of the Company.
Oct 2014
21 Oct · Board meeting
Inter-alia to consider and approve for following matters : 1. To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the second quarter and half year ended September 30, 2014. 2. To consider and recommend Interim Dividend, if any.21 Oct · Business
Share Allotment Committee of the Company has allotted 32,500 equity shares of face value of Rs. 5/- each in their meeting held on October 20, 2014, pursuant to the exercise of employee stock options by employees under Employee Stock option Scheme -2011 of the Company. Pursuant to the above, the paid up equity share capital of the Company will accordingly increase from Rs. 550,039,515/- (110,007,903 equity shares of Rs. 5/- each) to Rs. 550,202,015/- (110,040,403 equity shares of Rs. 5/- each).
Sep 2014
17 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2014
13 Aug · Meeting
Company has fixed Book Closure from September 8, 2014 to September 15, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company and declaration of Preference dividend.
Jul 2014
31 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the quarter ended June 30, 2014. Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from July 31, 2014 to August 13, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results are submitted to the stock exchanges.
Jun 2014
2 Jun · Business
Compensation Committee of the Board has granted 2,00,000 Stock Options @ Rs. 5/- per option to the employees of the Company, convertible into 2,00,000 equity shares of Rs. 5/- each under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999.
May 2014
28 May · Legal
Exchange had sought clarification from Wockhardt Limited with respect to news item captioned "USFDA raises concern over Wockhardt plant". The Company has clarified that "Inspection of plants by regulatory authorities such as US FDA are done in normal course of business and post inspection the authorities provide their observation to the Company on a form called FDA Form 483 . The Company is required to provide its response addressing each observation, based on which the authorities decide the further course of action. The Company s subsidiary Morton Grove Pharmaceuticals Ltd, based out of USA and having a manufacturing plant in Chicago has received FDA Form 483 . Kindly note that issuance of observations per se does not result in any material impact".26 May · Dividend
Board of Directors of the Company at its meeting held on May 26, 2014 recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs. 298,557/- on 475,659,941 Non-Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 121,454,927 Optionally Convertible Cumulative Redeemable Preference Shares of Rs. 5/- each. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.26 May · Board meeting
Board of Directors at its meeting held on May 26, 2014 has noted resignation of Mr. Vijay Khetan, Company Secretary & Compliance Officer with effect from May 30, 2014.